ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

STAMP2 Attenuates Cardiac Dysfunction and Insulin Resistance in Diabetic Cardiomyopathy via NMRAL1-Mediated NF-κB Inhibition in Type 2 Diabetic Rats.

Zhan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.